- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06274229
DivAirCity Social Health Survey (DivAirCitySH)
Anonymous Survey Among Local Residents on the Impact of the Planned Measures in the Five Partner Cities of the DivAirCity Project on Their Social Life, Health and Well-being
Study Overview
Status
Intervention / Treatment
Detailed Description
Scientific studies show that increased stress can favor the development of e.g. high blood pressure, heart disease, mental illness, infectious diseases, headaches and sleep disorders. This means that stress causes considerable costs for western healthcare systems, including in our city and this neighbourhood. In large cities, where there are often hardly any natural green and forest areas left, depression and anxiety syndromes, for example, are more common than among the rural population.
For example, in Germany, more than three quarters of the population live in densely or moderately populated areas, while the global average is more than 50 per cent. Due to increasing urbanisation, people living in cities will be heavily dependent on urban nature, which can be a relevant health-promoting factor. Several studies have shown that natural spaces such as city parks, parks and even greenery on streets have a positive impact on the health of residents, both individually and collectively.
The European Council Horizon 2020 project DivAirCity (acronym explanation in the text below) is about making formerly busy public spaces in European cities more attractive again for residents and citizens. The aim is to redesign the spaces in such a way that people of different age groups, social classes and identities ("Div") can (once again) come together and meet in these places on a daily basis. To this end, these places are to be changed through various installations (planting trees, redesigning parks, shading, watering in summer) in such a way that the local air quality ("Air") in the cities ("City") improves significantly. This is realized on the one hand by installing air quality measuring equipment and by recording the number of people and the time they spend in these places (objective measurements).
In addition to these objective measurements, this study records the impact on psychological and physiological health that the installations (intervention) has on the residents. To this end, it will be measured how residents feel in terms of quality of life, current stress, general health, and whether they feel safe and secure in the specific place (comfort, safety and security) and whether they enjoy going there and staying there,. These measurements will take place both before (day -60 to day -30) and after (day +30 and day +60) the installment of the intervention.
Finally, we would like to know your age group, your gender and how close you live to the location of the conversion/installation. We would like to invite you to take part in this survey again after the remodelling project.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Farid I Kandil, PhD
- Phone Number: 770 +493080505
- Email: farid-ihab.kandil@charite.de
Study Contact Backup
- Name: Etienne Hanslian, MD
- Phone Number: 770 +493080505
- Email: etienne.hanslian@charite.de
Study Locations
-
-
-
Berlin, Germany, 14109
- Recruiting
- Charité -- Universitaetsmedizin Berlin
-
Contact:
- Farid I Kandil, PhD
- Phone Number: +491605631744
- Email: farid-ihab.kandil@charite.de
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Participants must live or work at or near the installation (intervention group) or control site (control group)
Exclusion Criteria:
- none
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Aarhus, installation site
Residents of Aarhus (DK), living at or nearby the site of the installed Intervention
|
A number of means to reduce traffic noise and traffic exhausts and improve air quality will be implemented at designated urban spaces (intervention sites), while other places with comparable amount of traffic and no such changes will serve as control sites.
|
Aarhus, control site
Residents of Aarhus (DK), living at or nearby the control site
|
|
Bucharest, intervention site
Residents of Bucharest (RO), living at or nearby the site of the installed Intervention
|
A number of means to reduce traffic noise and traffic exhausts and improve air quality will be implemented at designated urban spaces (intervention sites), while other places with comparable amount of traffic and no such changes will serve as control sites.
|
Bucharest, control site
Residents of Bucharest (RO), living at or nearby the control site
|
|
Castelló, intervention site
Residents of Castelló (ES), living at or nearby the site of the installed Intervention
|
A number of means to reduce traffic noise and traffic exhausts and improve air quality will be implemented at designated urban spaces (intervention sites), while other places with comparable amount of traffic and no such changes will serve as control sites.
|
Castelló, control site
Residents of Castelló (ES), living at or nearby the control site
|
|
Orvieto, intervention site
Residents of Orvieto (IT), living at or nearby the site of the installed Intervention
|
A number of means to reduce traffic noise and traffic exhausts and improve air quality will be implemented at designated urban spaces (intervention sites), while other places with comparable amount of traffic and no such changes will serve as control sites.
|
Orvieto, control site
Residents of Orvieto (IT), living at or nearby the control site
|
|
Potsdam, intervention site
Residents of Potsdam (DE), living at or nearby the site of the installed Intervention
|
A number of means to reduce traffic noise and traffic exhausts and improve air quality will be implemented at designated urban spaces (intervention sites), while other places with comparable amount of traffic and no such changes will serve as control sites.
|
Potsdam, control site
Residents of Potsdam (DE), living at or nearby the control site
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
WHO-5 Well-being Scale
Time Frame: Baseline: 60 to 30 days before the installation implementation vs Posttest: 30 to 60 days after the installation has been implemented
|
Validated Questionnaire
|
Baseline: 60 to 30 days before the installation implementation vs Posttest: 30 to 60 days after the installation has been implemented
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Kessler K6 psychological distress
Time Frame: Baseline: 60 to 30 days before the installation implementation vs Posttest: 30 to 60 days after the installation has been implemented
|
Validated Questionnaire
|
Baseline: 60 to 30 days before the installation implementation vs Posttest: 30 to 60 days after the installation has been implemented
|
ASKU questionnaire
Time Frame: Baseline: 60 to 30 days before the installation implementation vs Posttest: 30 to 60 days after the installation has been implemented
|
Validates Questionnaire for self-efficacy
|
Baseline: 60 to 30 days before the installation implementation vs Posttest: 30 to 60 days after the installation has been implemented
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Questionnaire for General Physiological Health
Time Frame: Baseline: 60 to 30 days before the installation implementation vs Posttest: 30 to 60 days after the installation has been implemented
|
Custom-made Questionnaire
|
Baseline: 60 to 30 days before the installation implementation vs Posttest: 30 to 60 days after the installation has been implemented
|
Questionnaire about feelings of safety and security at the site
Time Frame: Baseline: 60 to 30 days before the installation implementation vs Posttest: 30 to 60 days after the installation has been implemented
|
Custom-made Questionnaire
|
Baseline: 60 to 30 days before the installation implementation vs Posttest: 30 to 60 days after the installation has been implemented
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Andreas Michalsen, Prof MD, Charite Universitaetsmedizin Berlin
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- EA4/252/23
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pollution; Exposure
-
Environmental Protection Agency (EPA)Enrolling by invitationAir Pollution | Pollution; Exposure | Nutrition, HealthyUnited States
-
Stanford UniversityJohns Hopkins University; University at Buffalo; International Centre for Diarrhoeal...Completed
-
Medical College of WisconsinUniversity of Wisconsin, MilwaukeeCompletedPollution; ExposureUnited States
-
Oregon State UniversityNational Institute of Environmental Health Sciences (NIEHS); Oregon Health...RecruitingPollution; ExposureUnited States
-
Helmholtz Centre for Environmental Research - UFZDuke University; Seoul National University; University Hospital, AntwerpNot yet recruitingExposure to PollutionGermany
-
Environmental Protection Agency (EPA)CompletedExposure to PollutionUnited States
-
Université de MontréalCompletedExposure to Pollution
-
State University of New York at BuffaloNot yet recruitingPollution; Exposure | Physical InactivityUnited States
-
King's College LondonPublic Health England; National Institute for Health Research, United KingdomCompletedHealth Behavior | Pollution; ExposureUnited Kingdom
-
Assaf-Harofeh Medical CenterActive, not recruitingExposure to Environmental PollutionIsrael
Clinical Trials on Air pollution and noise reducing installations
-
University of California, San FranciscoUnknownHealth Behavior | Pollution Related Respiratory Disorder | Attitude to HealthUnited States
-
MASK-air SASCompletedAllergic Rhinitis Due to Pollen | Allergic Rhinitis With AsthmaFrance
-
Medical University of BialystokCompletedCardiovascular Diseases | Acute Coronary Syndrome | Cardiovascular Risk Factor | Pollution; Exposure | Particulate Matter Inhalation Injury | Chronic Coronary InsufficiencyPoland
-
First Affiliated Hospital Xi'an Jiaotong UniversityRecruitingAdverse Pregnancy OutcomesChina
-
Aina ChalabaevInstitut National de la Santé Et de la Recherche Médicale, France; Institut... and other collaboratorsEnrolling by invitationAutomobile Driving | Active CommutingFrance
-
University Hospital, UmeåKing's College LondonCompletedAllergic RhinitisSweden
-
Paris 12 Val de Marne UniversityNational Research Agency, France; Institut National de Recherche pour l'Agriculture... and other collaboratorsRecruitingHealth-Related BehaviorFrance
-
First Affiliated Hospital Xi'an Jiaotong UniversityThe First Affiliated Hospital of the Fourth Military Medical UniversityRecruiting
-
University GhentCompletedDiet ModificationBelgium
-
Eli Lilly and CompanyCompletedMigraineUnited States, Puerto Rico, Japan